_id
691afe9f3c536f8df2318888
Ticker
SBX.XETRA
Name
SynBiotic SE
Exchange
XETRA
Address
Barer Strasse 7, Munich, Germany, 80333
Country
Germany
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
EUR
Website
https://www.synbiotic.com
Description
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2017 and is based in Munich, Germany.
Last Close
3.065
Volume
6825
Current Price
3.175
Change
-7.993474714518764
Last Updated
2025-12-30T12:21:34.750Z
Image
https://logo.clearbit.com/www.synbiotic.com
Ipo Date
-
Market Cap
17423490
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-06-30
Revenue
3549.5
Cost Of Revenue
2098
Gross Profit
1451.5
Operating Expenses
917
Operating Income
534.5
Interest Expense
31561
Pretax Income
-992
Net Income
-684778
Eps
-0.13089750633003824
Dividends Per Share
-
Shares Outstanding
5599537
Income Tax Expense
-
EBITDA
-495895
Operating Margin
15.058458937878575
Total Other Income Expense Net
-1526.5
Cash
69884
Short Term Investments
-
Receivables
11840773
Inventories
-
Total Current Assets
12062189
Property Plant Equipment
1
Total Assets
58172398
Payables
3197237
Short Term Debt
-
Long Term Debt
-
Total Liabilities
10922887
Equity
47249510
Bs_currency_symbol
-
Depreciation
157326
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.3515319851994232
ROE
-1.4492806380425955
ROA
-1.1771527795708199
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
3549.5
Quarters > 0 > income Statement > cost Of Revenue
2098
Quarters > 0 > income Statement > gross Profit
1451.5
Quarters > 0 > income Statement > operating Expenses
917
Quarters > 0 > income Statement > operating Income
534.5
Quarters > 0 > income Statement > interest Expense
31561
Quarters > 0 > income Statement > pretax Income
-992
Quarters > 0 > income Statement > net Income
-684778
Quarters > 0 > income Statement > eps
-0.13089750633003824
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5231406
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-495895
Quarters > 0 > income Statement > operating Margin
15.058458937878575
Quarters > 0 > income Statement > total Other Income Expense Net
-1526.5
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
69884
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11840773
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12062189
Quarters > 0 > balance Sheet > property Plant Equipment
1
Quarters > 0 > balance Sheet > total Assets
58172398
Quarters > 0 > balance Sheet > payables
3197237
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10922887
Quarters > 0 > balance Sheet > equity
47249510
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-992
Quarters > 0 > cash Flow > depreciation
157326
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.13089750633003824
Quarters > 0 > ratios > PB
0.3515319851994232
Quarters > 0 > ratios > ROE
-1.4492806380425955
Quarters > 0 > ratios > ROA
-1.1771527795708199
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
3549.5
Quarters > 1 > income Statement > cost Of Revenue
2098
Quarters > 1 > income Statement > gross Profit
1451.5
Quarters > 1 > income Statement > operating Expenses
917
Quarters > 1 > income Statement > operating Income
534.5
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-992
Quarters > 1 > income Statement > net Income
-992
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-840.98
Quarters > 1 > income Statement > operating Margin
15.058458937878575
Quarters > 1 > income Statement > total Other Income Expense Net
-1526.5
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-15327
Quarters > 1 > balance Sheet > equity
15327
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-992
Quarters > 1 > cash Flow > depreciation
217.02
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-6.472238533307236
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
48
Quarters > 2 > quarter
2023-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
122085
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4184055
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
966556
Quarters > 3 > balance Sheet > short Term Investments
2067848
Quarters > 3 > balance Sheet > receivables
305890
Quarters > 3 > balance Sheet > inventories
3348320
Quarters > 3 > balance Sheet > total Current Assets
8046249
Quarters > 3 > balance Sheet > property Plant Equipment
5416058
Quarters > 3 > balance Sheet > total Assets
40623742
Quarters > 3 > balance Sheet > payables
1973799
Quarters > 3 > balance Sheet > short Term Debt
902112
Quarters > 3 > balance Sheet > long Term Debt
3079139
Quarters > 3 > balance Sheet > total Liabilities
17834119
Quarters > 3 > balance Sheet > equity
22593075
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
54880
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
0.5879843547193111
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
3861356
Annuals > 0 > income Statement > cost Of Revenue
2354938
Annuals > 0 > income Statement > gross Profit
1506418
Annuals > 0 > income Statement > operating Expenses
12718000
Annuals > 0 > income Statement > operating Income
-11211581
Annuals > 0 > income Statement > interest Expense
195237
Annuals > 0 > income Statement > pretax Income
-11871183
Annuals > 0 > income Statement > net Income
-10630597
Annuals > 0 > income Statement > eps
-2.2383427424075384
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4749316
Annuals > 0 > income Statement > income Tax Expense
-134909
Annuals > 0 > income Statement > EBITDA
-10567788
Annuals > 0 > income Statement > operating Margin
-290.3534665024411
Annuals > 0 > income Statement > total Other Income Expense Net
-659602
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
89212
Annuals > 0 > balance Sheet > short Term Investments
2706876
Annuals > 0 > balance Sheet > receivables
565036
Annuals > 0 > balance Sheet > inventories
2829818
Annuals > 0 > balance Sheet > total Current Assets
6530462
Annuals > 0 > balance Sheet > property Plant Equipment
4888623
Annuals > 0 > balance Sheet > total Assets
34918165
Annuals > 0 > balance Sheet > payables
2361111
Annuals > 0 > balance Sheet > short Term Debt
786809
Annuals > 0 > balance Sheet > long Term Debt
2563147
Annuals > 0 > balance Sheet > total Liabilities
19590967
Annuals > 0 > balance Sheet > equity
15789870
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-10630597
Annuals > 0 > cash Flow > depreciation
4553347
Annuals > 0 > cash Flow > change In Working Capital
942102
Annuals > 0 > cash Flow > cash From Operations
-2924295
Annuals > 0 > cash Flow > capital Expenditures
19181
Annuals > 0 > cash Flow > cash From Investing
-732786
Annuals > 0 > cash Flow > cash From Financing
2780437
Annuals > 0 > cash Flow > net Change In Cash
-876644
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-2.2383427424075384
Annuals > 0 > ratios > PB
0.8076009150170331
Annuals > 0 > ratios > ROE
-67.32542446517927
Annuals > 0 > ratios > ROA
-30.444317449098484
Annuals > 0 > ratios > FCF
-2943476
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.7622907600335219
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
8165626
Annuals > 1 > income Statement > cost Of Revenue
4593492
Annuals > 1 > income Statement > gross Profit
3572134
Annuals > 1 > income Statement > operating Expenses
6377930
Annuals > 1 > income Statement > operating Income
-9010051
Annuals > 1 > income Statement > interest Expense
188898
Annuals > 1 > income Statement > pretax Income
-26186438
Annuals > 1 > income Statement > net Income
-24362172
Annuals > 1 > income Statement > eps
-5.896171291255301
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4131863
Annuals > 1 > income Statement > income Tax Expense
-188811
Annuals > 1 > income Statement > EBITDA
-24172350
Annuals > 1 > income Statement > operating Margin
-110.34121572553042
Annuals > 1 > income Statement > total Other Income Expense Net
-17176387
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
966556
Annuals > 1 > balance Sheet > short Term Investments
2067848
Annuals > 1 > balance Sheet > receivables
305890
Annuals > 1 > balance Sheet > inventories
3398825
Annuals > 1 > balance Sheet > total Current Assets
8046249
Annuals > 1 > balance Sheet > property Plant Equipment
5416058
Annuals > 1 > balance Sheet > total Assets
40623742
Annuals > 1 > balance Sheet > payables
1973799
Annuals > 1 > balance Sheet > short Term Debt
902112
Annuals > 1 > balance Sheet > long Term Debt
3079139
Annuals > 1 > balance Sheet > total Liabilities
17834119
Annuals > 1 > balance Sheet > equity
22593075
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-24362172
Annuals > 1 > cash Flow > depreciation
1598897
Annuals > 1 > cash Flow > change In Working Capital
-97310
Annuals > 1 > cash Flow > cash From Operations
-6995543
Annuals > 1 > cash Flow > capital Expenditures
478154
Annuals > 1 > cash Flow > cash From Investing
-68157
Annuals > 1 > cash Flow > cash From Financing
4828199
Annuals > 1 > cash Flow > net Change In Cash
-2235501
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-5.896171291255301
Annuals > 1 > ratios > PB
0.4910377252764398
Annuals > 1 > ratios > ROE
-107.83026214891068
Annuals > 1 > ratios > ROA
-59.97028043354548
Annuals > 1 > ratios > FCF
-7473697
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.9152632021108975
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
9063712
Annuals > 2 > income Statement > cost Of Revenue
3863180
Annuals > 2 > income Statement > gross Profit
5200532
Annuals > 2 > income Statement > operating Expenses
16636330
Annuals > 2 > income Statement > operating Income
-5578609
Annuals > 2 > income Statement > interest Expense
46644
Annuals > 2 > income Statement > pretax Income
-13359321
Annuals > 2 > income Statement > net Income
-12724610
Annuals > 2 > income Statement > eps
-4.09876176557843
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3104501
Annuals > 2 > income Statement > income Tax Expense
-289711
Annuals > 2 > income Statement > EBITDA
-10616770
Annuals > 2 > income Statement > operating Margin
-61.54883341394783
Annuals > 2 > income Statement > total Other Income Expense Net
-7780712
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
3202057
Annuals > 2 > balance Sheet > short Term Investments
2036913
Annuals > 2 > balance Sheet > receivables
727380
Annuals > 2 > balance Sheet > inventories
3470377
Annuals > 2 > balance Sheet > total Current Assets
10585132
Annuals > 2 > balance Sheet > property Plant Equipment
5862430
Annuals > 2 > balance Sheet > total Assets
60647167
Annuals > 2 > balance Sheet > payables
2213250
Annuals > 2 > balance Sheet > short Term Debt
242861
Annuals > 2 > balance Sheet > long Term Debt
2489279
Annuals > 2 > balance Sheet > total Liabilities
23922406
Annuals > 2 > balance Sheet > equity
34999860
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-12724610
Annuals > 2 > cash Flow > depreciation
744584
Annuals > 2 > cash Flow > change In Working Capital
-581471
Annuals > 2 > cash Flow > cash From Operations
-5144135
Annuals > 2 > cash Flow > capital Expenditures
365612
Annuals > 2 > cash Flow > cash From Investing
-3059213
Annuals > 2 > cash Flow > cash From Financing
5415117
Annuals > 2 > cash Flow > net Change In Cash
-2788231
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-4.09876176557843
Annuals > 2 > ratios > PB
0.23816052935640317
Annuals > 2 > ratios > ROE
-36.35617399612456
Annuals > 2 > ratios > ROA
-20.981375766488814
Annuals > 2 > ratios > FCF
-5509747
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.6078907847027796
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
5472181
Annuals > 3 > income Statement > cost Of Revenue
1733247
Annuals > 3 > income Statement > gross Profit
3738934
Annuals > 3 > income Statement > operating Expenses
841553
Annuals > 3 > income Statement > operating Income
2897381
Annuals > 3 > income Statement > interest Expense
22873
Annuals > 3 > income Statement > pretax Income
-858798
Annuals > 3 > income Statement > net Income
-880389
Annuals > 3 > income Statement > eps
-0.553444455270958
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1590745
Annuals > 3 > income Statement > income Tax Expense
21591
Annuals > 3 > income Statement > EBITDA
-716121
Annuals > 3 > income Statement > operating Margin
52.94746281235946
Annuals > 3 > income Statement > total Other Income Expense Net
-3756179
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
5990288
Annuals > 3 > balance Sheet > short Term Investments
52137
Annuals > 3 > balance Sheet > receivables
921994
Annuals > 3 > balance Sheet > inventories
524763
Annuals > 3 > balance Sheet > total Current Assets
7692392
Annuals > 3 > balance Sheet > property Plant Equipment
23160
Annuals > 3 > balance Sheet > total Assets
35027400
Annuals > 3 > balance Sheet > payables
669544
Annuals > 3 > balance Sheet > short Term Debt
114884
Annuals > 3 > balance Sheet > long Term Debt
252000
Annuals > 3 > balance Sheet > total Liabilities
9530362
Annuals > 3 > balance Sheet > equity
25485599
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-880389
Annuals > 3 > cash Flow > depreciation
119804
Annuals > 3 > cash Flow > change In Working Capital
-520448
Annuals > 3 > cash Flow > cash From Operations
-1263361
Annuals > 3 > cash Flow > capital Expenditures
2137182
Annuals > 3 > cash Flow > cash From Investing
-1126484
Annuals > 3 > cash Flow > cash From Financing
8366884
Annuals > 3 > cash Flow > net Change In Cash
5977039
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.553444455270958
Annuals > 3 > ratios > PB
0.1675907372237945
Annuals > 3 > ratios > ROE
-3.4544567698801196
Annuals > 3 > ratios > ROA
-2.5134294866304665
Annuals > 3 > ratios > FCF
-3400543
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.6214237065623378
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.13089750633003824
Valuation > metrics > PB
0.3515319851994232
Valuation > final Score
70
Valuation > verdict
64.8% Undervalued
Profitability > metrics > ROE
-1.4492806380425955
Profitability > metrics > ROA
-5.677062430376443
Profitability > metrics > Net Margin
-192.92238343428653
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.23117460900652725
Risk > metrics > Interest Coverage
0.01693545831881119
Risk > final Score
60
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.7726915458566257
Liquidity > metrics > Quick Ratio
3.7726915458566257
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
74
Prev Risks > 1
50
Prev Risks > 2
68
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T23:07:39.205Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-08-16
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-06-30
Earnings History > 1 > report Date
2021-09-28
Earnings History > 1 > date
2021-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
EUR
Earnings History > 1 > eps Actual
-0.13
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.13
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-03-31
Earnings History > 2 > report Date
2021-06-30
Earnings History > 2 > date
2021-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.95
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.95
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-06-30
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.04
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.04
Earnings History > 3 > surprise Percent
-
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2017 and is based in Munich, Germany.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASBX.DE SynBiotic SE (XETRA) down 17.59% intraday: watch cash runway Meyka
Read more →(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of SynBiotic SE
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2024-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.